SMITHA JOHN: Open Payments
NPI 1083460216 · LAKE JACKSON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,860 in 98 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $313 · 2025 $1,860
Food & beverage: $1,860
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 28 | $341 |
| Neurocrine BioSciences, Inc. | 10 | $339 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $254 |
| Otsuka America Pharmaceutical, Inc. | 6 | $210 |
| ACADIA Pharmaceuticals Inc | 4 | $160 |
| Lundbeck LLC | 5 | $100 |
| Teva Pharmaceuticals USA, Inc. | 4 | $77 |
| E.R. Squibb & Sons, L.L.C. | 4 | $73 |
| Corium, LLC | 5 | $68 |
| Axsome Therapeutics, Inc. | 3 | $62 |
Products named: VRAYLAR, REXULTI, CAPLYTA, INGREZZA, NUPLAZID, AUSTEDO XR, COBENFY, Azstarys.
Industry payments across TX — which companies pay providers there.
